|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$97,005
|
N/A
|
National Cancer Institute
|
|
TAS::75 0849::TAS Incremental Funding
|
261200800001E-51
|
$271,391,560
|
$1,272,705
|
Heimbrook, David
|
SAIC-FREDERICK, INC.
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-12
|
$23,766,226
|
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support (CORE) Grant
|
2P30CA016672-38
|
$9,725,847
|
$97,258
|
DEPINHO, RONALD
|
UT MD ANDERSON CANCER CTR
|
|
Cancer Center Core Support Grant
|
5P30CA016086-37
|
$6,721,410
|
$67,214
|
EARP, HENRY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Center Support Grant
|
5P30CA068485-17
|
$5,600,513
|
$616,056
|
Pietenpol, Jennifer
|
VANDERBILT UNIVERSITY MED CTR
|
|
Cancer Center Support Grant
|
5P30CA016058-37
|
$4,284,455
|
$42,845
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Core Support for Cancer Center
|
2P30CA013330-40
|
$3,589,611
|
$107,688
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
Surgical Consultants & Collaborative Research Involving Surgical Services at NIH
|
ZID SC 003800
|
$3,204,789
|
$160,239
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Cancer Center Support Grant-P30
|
5P30CA093373-11
|
$3,034,249
|
$60,685
|
de Vere White, Ralph
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Cancer Center Support Grant
|
3P30CA072720-19S6
|
$2,945,906
|
|
LIBUTTI, STEVEN
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
Innovative Infrastructure to Enhance the California Teachers Study
|
5U01CA199277-04
|
$2,520,260
|
|
LACEY, JAMES
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
High-throughput in vivo genetics for immunotherapy target discovery
|
1DP2CA238295-01
|
$2,512,500
|
|
CHEN, SIDI
|
YALE UNIVERSITY
|
|
Case GI SPORE
|
5P50CA150964-07
|
$2,500,000
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Medical Director's Office
|
ZID BC 010951
|
$2,426,933
|
$24,269
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Dietary and Hormonal Determinants of Cancer in Women
|
5P01CA087969-19
|
$2,402,014
|
|
STAMPFER, MEIR
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cellular and Molecular Studies of Bone Marrow Transplant
|
5P01CA039542-30
|
$2,257,066
|
|
FERRARA, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Development of Novel Therapeutic Strategies in Human Leukemias
|
5P01CA066996-20
|
$2,247,411
|
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
I-SPY2 +: Evolving the I-SPY 2 TRIAL to include MRI-directed, adaptive sequential treatment to optimize breast cancer outcomes
|
5P01CA210961-02
|
$2,124,555
|
|
ESSERMAN, LAURA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
The UT MD Anderson Cancer Center Community Clinical Oncology Program Research Bas
|
5U10CA045809-25
|
$1,885,277
|
$18,853
|
FISCH, MICHAEL
|
UT MD ANDERSON CANCER CTR
|
|
H. Pylori-Induced Inflammation and Gastric Cancer
|
5P01CA116087-05
|
$1,252,598
|
$1,252,598
|
PEEK, RICHARD
|
VANDERBILT UNIVERSITY MED CTR
|
|
CELLULAR AND MOLECULAR MECHANISMS OF GASTROINTESTINAL CANCERS
|
5P01CA130821-06
|
$1,230,089
|
$307,522
|
MISHRA, LOPA
|
UT MD ANDERSON CANCER CTR
|
|
Integrated Molecular, Cellular, and Imaging Characterization of Screen-Detected Lung Cancer
|
5U01CA196408-04
|
$1,218,395
|
|
DUBINETT, STEVEN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,207,080
|
$24,142
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Accelerated discovery of methylation targeted therapeutic development
|
2R44CA212733-02
|
$1,148,788
|
|
SUN, ZU-WEN
|
EPICYPHER, INC.
|
|
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
|
5U01CA196390-04
|
$1,122,515
|
|
PIENTA, KENNETH
|
JOHNS HOPKINS UNIVERSITY
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,117,473
|
$55,874
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
|
5U01CA196403-04
|
$1,107,123
|
|
MAITRA, ANIRBAN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-13
|
$1,101,004
|
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
The Role of the Microenvironment in Barretts Esophagus
|
5U54CA163004-07
|
$1,085,045
|
|
WANG, TIMOTHY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Families at high risk of cancer
|
ZIA CP004410-08285
|
$1,048,784
|
$20,976
|
Caporaso, Neil
|
DCEG (NCI)
|
|
Programmable Individualized NRT Merged With Digital Behavioral Support
|
5R44CA171786-05
|
$1,000,000
|
|
LEVY, ALAN
|
CHRONO THERAPEUTICS, INC.
|
|
DEVELOPMENT OF A WNT PATHWAY INHIBITOR FOR METASTATIC COLORECTAL CANCER
|
5R44CA144177-05
|
$999,998
|
|
ORTON, DARREN
|
STEMSYNERGY THERAPEUTICS, INC.
|
|
A Prognostic Blood Test to Monitor Pancreatic Cancer Treatment by MiRNA Profiling
|
2R44CA199058-02
|
$999,597
|
|
SARAF, RAVI
|
VAJRA INSTRUMENTS, INC.
|
|
A Novel PET Probe for Use in Cancer Diagnostics
|
5R44CA216539-03
|
$999,412
|
|
MOORE, MELISSA
|
SOFIE BIOSCIENCES, INC.
|
|
Molecular Imaging and Theranostics of Cancer
|
5R35CA209960-02
|
$981,390
|
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
Pancreatic Ductal Adenocarcinoma Targeted Ultrasound Contrast Agent Development
|
2R44CA203090-02
|
$963,578
|
|
UNGER, EVAN
|
NUVOX PHARMA, LLC
|
|
Etiological Studies of Gastric Carcinoma
|
5P01CA028842-28
|
$961,747
|
$961,747
|
Correa, PELAYO
|
VANDERBILT UNIVERSITY MED CTR
|
|
Metabolic Regulators of Tumor Growth and Progression
|
5R35CA220449-02
|
$945,631
|
|
DEBERARDINIS, RALPH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Real-time volumetric specimen imager for 3D intra-operative lumpectomy margin assessment
|
2R44CA206801-02
|
$920,127
|
|
HAN, XIAO
|
CLARIX IMAGING CORPORATION
|
|
Optimizing Hematopoietic Stem Cell Transplantation for the Treatment of Hematological Malignancies
|
5R35CA210084-02
|
$915,000
|
|
DIPERSIO, JOHN
|
WASHINGTON UNIVERSITY
|
|
Immuno-Targeted Therapy for Melanoma
|
5R35CA197633-04
|
$899,241
|
|
RIBAS, ANTONI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Risk Reduction and Diet: A Cohort Study of Women
|
5R37CA070867-16
|
$894,579
|
$223,645
|
ZHENG, WEI
|
VANDERBILT UNIVERSITY MED CTR
|
|
Intracellular In vivo Imaging
|
ZIA BC 010657
|
$880,260
|
$88,026
|
Choyke, Peter
|
CCR (NCI)
|
|
Transcription Regulation in E. coli and H. pylori
|
ZIA BC 010632
|
$847,929
|
$423,964
|
Jin, Ding
|
CCR (NCI)
|
|
Model-based Prediction of Redox-Modulated Responses to Cancer Treatments
|
5U01CA215848-02
|
$825,581
|
|
KEMP, MELISSA
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
Longitudinal models of breast cancer for studying mechanisms of therapy response and resistance
|
1U01CA217617-01A1
|
$822,738
|
|
WELM, BRYAN
|
UNIVERSITY OF UTAH
|
|
The EDRN Mesothelioma Biomarker Discovery Laboratory
|
5U01CA214195-03
|
$812,360
|
|
PASS, HARVEY
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A Phase II trial of abiraterone in combination with PDMX1001 in enzalutamide-resistant prostate cancer
|
2R44CA206668-02A1
|
$754,319
|
|
LIU, CHENGFEI
|
PANDOMEDX, INC.
|
|
IND-Enabling Studies of ZB716, an Orally Bioavailable SERD
|
2R44CA213462-02
|
$748,371
|
|
WANG, GUANGDI
|
ZENOPHARM, LLC
|
Total relevant funding to Stomach for this search: $11,367,881
|